Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Walker

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Bacterial iron acquisition mediated by outer membrane translocation and cleavage of a host proteinKhedidja Mosbahi, Marta Wojnowska, Amaya Albalat, et al.
Biochemical Society Transactions|November 27, 2012
Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infectionCarla L Brown, Karen Smith, Laura McCaughey, et al.
Emerging Topics in Life Sciences|February 2, 2021
The therapeutic potential of bacteriocins as protein antibioticsHannah M Behrens, Anne Six, Daniel Walker, et al.
Journal of the American Academy of Dermatology|March 14, 2017
Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort VDaniel Walker, Joseph S Susa, Sharif Currimbhoy, et al.
Probiotics and Antimicrobial Proteins|July 21, 2018
Screening of the Enterocin-Encoding Genes and Their Genetic Determinism in the Bacteriocinogenic Enterococcus faecium GHB21Mohamed Merzoug, Khédidja Mosbahi, Daniel Walker, et al.
Biochemistry|April 19, 2003
Thermodynamic consequences of bipartite immunity protein binding to the ribosomal ribonuclease colicin E3Daniel Walker, Geoffrey R Moore, Richard James, et al.
Inflammatory Bowel Diseases|July 16, 2015
Activity of Species-specific Antibiotics Against Crohn's Disease-Associated Adherent-invasive Escherichia coliCarla L Brown, Karen Smith, Daniel M Wall, et al.
Health Affairs (Project Hope)|November 5, 2014
Identifying hospitals that may be at most financial risk from Medicaid disproportionate-share hospital payment cutsEvan S Cole, Daniel Walker, Arthur Mora, et al.
Frontiers in Microbiology|October 12, 2020
Bacteriocins Targeting Gram-Negative Phytopathogenic Bacteria: Plantibiotics of the FutureWilliam M Rooney, Ray Chai, Joel J Milner, et al.
Pest Management Science|February 2, 2021
Challenges of using protein antibiotics for pathogen controlRay Chai, William M Rooney, Joel J Milner, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Bacterial iron acquisition mediated by outer membrane translocation and cleavage of a host proteinKhedidja Mosbahi, Marta Wojnowska, Amaya Albalat, et al.
Biochemical Society Transactions|November 27, 2012
Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infectionCarla L Brown, Karen Smith, Laura McCaughey, et al.
Emerging Topics in Life Sciences|February 2, 2021
The therapeutic potential of bacteriocins as protein antibioticsHannah M Behrens, Anne Six, Daniel Walker, et al.
Journal of the American Academy of Dermatology|March 14, 2017
Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort VDaniel Walker, Joseph S Susa, Sharif Currimbhoy, et al.
Probiotics and Antimicrobial Proteins|July 21, 2018
Screening of the Enterocin-Encoding Genes and Their Genetic Determinism in the Bacteriocinogenic Enterococcus faecium GHB21Mohamed Merzoug, Khédidja Mosbahi, Daniel Walker, et al.
Biochemistry|April 19, 2003
Thermodynamic consequences of bipartite immunity protein binding to the ribosomal ribonuclease colicin E3Daniel Walker, Geoffrey R Moore, Richard James, et al.
Inflammatory Bowel Diseases|July 16, 2015
Activity of Species-specific Antibiotics Against Crohn's Disease-Associated Adherent-invasive Escherichia coliCarla L Brown, Karen Smith, Daniel M Wall, et al.
Health Affairs (Project Hope)|November 5, 2014
Identifying hospitals that may be at most financial risk from Medicaid disproportionate-share hospital payment cutsEvan S Cole, Daniel Walker, Arthur Mora, et al.
Frontiers in Microbiology|October 12, 2020
Bacteriocins Targeting Gram-Negative Phytopathogenic Bacteria: Plantibiotics of the FutureWilliam M Rooney, Ray Chai, Joel J Milner, et al.
Pest Management Science|February 2, 2021
Challenges of using protein antibiotics for pathogen controlRay Chai, William M Rooney, Joel J Milner, et al.
Pageof 14